Français | English

A group based on complementary expertise with multidisciplinary know-how

A range of integrated biotechnology solutions

A complete platform, from DNA to recombinant antibodies

News

IL1RAP, a therapeutic target for oncologic treatment

Date of publication : 31/07/2020

IL1-RAP, has been identified as a marker of interest in the context of CML treatments, activating NK cells and blocking tumour growth at the same time. Diaclone and Inserm teams  have been able to develop a CAR-T therapy to specifically target this biomarker, which has demonstrated great promise during preclinical studies.

Read more on Linked In

Discover Diaclone's new IL1RAP clones:

Anti-Human IL1RAP B-L43 Azide Free      
Anti-Human IL1RAP B-R58 Azide Free      
Anti-Human IL1RAP B-L43 Unconjugated      
Anti-Human IL1RAP B-R58 Unconjugated      

 

Another immuno-oncology target you would like to discuss?

Not fully aware of our complete immuno-oncology portfolio

Time to get in touch with the Diaclone team!

  • New at Diaclone - SARS-CoV-2 ELISA set
    Date of publication : 24/11/2020

    Diaclone continues to innovate and provide you with new research tools.

    Build your own serological assay with our new SARS-CoV-2 ELISA set.
    Contact Diaclone for more information...

    Read more
  • HEK293: when the virus meets the cell...
    Date of publication : 20/11/2020

    All you need to know about HEK293 cells...

    And you, are you currently working on recombinant protein expression?

    Do you need a helping hand with the viral transfection of HEK293?

    Read more...

    Read more
  • Trail, the new Grail?
    Date of publication : 20/11/2020

    Diaclone has developed its TRAIL portfolio offering cytometry reagents, biologically active antibodies as well as kits for the determination of soluble forms of TRAIL and TRAIL receptors. Diaclone...

    Read more
  • Discover Diaclone's IL-1 Beta Monoclonal Antibody product range....
    Date of publication : 20/11/2020

    Diaclone have developed IL-1β monoclonal antibodies (the B-A15 clone, biologically active form) and immunoassays (ELISA and ELISpot kits) to help you monitor the immune responses to diverse...

    Read more
  • 8th Antibody Industrial Symposium 2020 (AIS 2020)
    Date of publication : 16/11/2020

    Diaclone will be present at the virtualized 8th Antibody Industrial Symposium 2020 (AIS 2020)  “Multispecific Abs, Ab-like molecules and adoptive cell therapy for fighting diseases”...

    Read more
  • BioFIT 9th Edition 7th - 10th December 2020
    Date of publication : 16/11/2020

    BioFIT 2020 100% Digital

    The mAbexperts group is a « virtual exhibitor » at the 9th Edition of Biofit.

    We will be happy to present to you the services & products of...

    Read more
  • NEW AT DIACLONE!... RECOMBINANT HUMAN SARS-CoV-2 PROTEINS
    Date of publication : 15/10/2020
    Developed in our laboratories in France Read more
  • 20 percent discount
    Diaclone - mAbs, ELISA, ELISpot, protéines : Profitez d'une remise de 20%!
    Date of publication : 07/10/2020
  • Covid-19 Toolbox of the mAbexperts group
    Date of publication : 05/08/2020
  • RD-Biotech - Benefit from a discount on FastELISA kits!
    Date of publication : 03/08/2020
  • Anti-S1 Domain Spike Protein is now available at Diaclone
    Date of publication : 03/08/2020


    Ideal for your COVID-19 studies...

    The antibody Anti-SARS-CoV-2 Spike S1 Protein CR3022 recognizes the S1 domain of the SARS-CoV Spike protein (aa318-510) as well as SARS-CoV-2 (COVID-19)...

    Read more
  • IL1RAP, a therapeutic target for oncologic treatment
    Date of publication : 31/07/2020

    IL1-RAP, has been identified as a marker of interest in the context of CML treatments, activating NK cells and blocking tumour growth at the same time. Diaclone and Inserm teams  have been able...

    Read more
  • Do you know the real potential of AAV?
    Date of publication : 01/07/2020

    Revealing the full potential of Adeno Associated Virus thanks to molecular biology

    Adeno-associated virus (AAV) is a small and single-strand DNA virus. In 1960, this non-enveloped entity was...

    Read more
  • What you need to know about Exosomes
    Date of publication : 01/07/2020

    “Huge opportunities”. “Many hurdles”. “Enormous potential”...

    It's just an excerpt of the several terms you'll come across if you search for them on...

    Read more
  • Complete Proteome of COVID-19
    Date of publication : 15/06/2020

    Are you familiar with all the proteins of SARS-CoV-2?

    Read more on Linked In

    Are you working on any of these proteins?

    Which one would you like to see developed and validated?

    Contact...

    Read more
  • RD-Biotech supplier of murine monoclonal antibodies D1-25 and 1112-1, for the quantification of rabies virus by ELISA.
    Date of publication : 15/06/2020

    Signature of  license agreement with Institut Pasteur (France) and the Winstar Institute (USA). RD-Biotech becomes the supplier of the clones D1-25 and 1112-1 and now offers the antibody pair...

    Read more
  • Patients’ Immune Battle Against COVID-19
    Date of publication : 27/05/2020

    A brief review of the expected complications of CovId-19 infection.

    Read more on Linked In

    Diaclone offers a specific range of Antibodies, ELISA and ELISpot kits for COVID-19 research that can...

    Read more
  • Fast track your Covid-19 Research with Diaclone’s CYTOKINES
    Date of publication : 26/05/2020

    Diaclone manufactures essential tools for Cytokine Storm monitoring & Immunotherapy...

    Read more
  • Latest News on COVID-19
    Date of publication : 06/05/2020

    With more than 3,000,000 cases and 200,000 deaths, and after three months of the worldwide outbreak, scientists keep on learning about COVID-19 every day.

    How can people be positively diagnosed...

    Read more
  • RD-Biotech : Here to help you in your Covid-19 related research projects
    Date of publication : 28/04/2020
  • depistage
    RD-BIOTECH is proud to produce the monoclonal antibodies used in the IVD RAPID TEST COVID-19 Ag Respi-Strip developed by CorisBioConcept!
    Date of publication : 03/04/2020

    RD-BIOTECH, a major French actor in the production of monoclonal antibodies and recombinant proteins, is proud to be a qualified Partner of the Belgian company  Coris BioConcept  regarding...

    Read more
  • Essential tools for COVID-19 and Immunotherapy research
    Date of publication : 03/04/2020
  • Human IL-6 cytokine, a useful tool for Coronavirus disease (COVID-19) and Immunotherapy research
    Date of publication : 20/03/2020




    DIACLONE provides a large panel of products for the quantification of human IL-6 and other human cytokines.
     





     

    Our Human IL-6 range...

    Read more
  • Bispecific Antibody: The Janus God of Therapeutics?
    Date of publication : 18/03/2020

    With 85 molecules under development and 3 approvals to date, it seems that bispecific antibodies may be the novel therapeutic booming class on the market...

    Read more on LinkedIn

    Since its...

    Read more
  • Future
    The Future of Therapeutic Antibody Development
    Date of publication : 12/03/2020

    The mAbexperts team has developed strong expertise in molecular biology to help you generate new formats of monoclonal antibodies.

    Read more on LinkedIn



     

    mAbexperts is a group...

    Read more
  • Antibody Humanization
    Date of publication : 05/03/2020

    Many articles about antibodies refer to the term “humanization”.  

    But what does humanization mean? What technical approaches are used to carry out such a process? What are the...

    Read more
  • In Gut We Trust... What is the microbiota and how does it influence our health?
    Date of publication : 10/02/2020

    Not a week goes by without a scientific article dealing with the microbiota. And we often hear that understanding the microbiota is explaining our illnesses. But what is exactly the microbiota and...

    Read more
  • Diaclone is a partner in a major European project involving a dozen partners from the Besançon region.
    Date of publication : 21/08/2018

    Le Projet MiMédi

    MIMEDI: MIcrotechnique pour les MEDicaments Innovants nouvelles solutions technologiques pour optimiser la fabrication de "cellules médicaments"

    Au sein...

    Read more